OpenLegislation

Division 3.6.2.2.6 Some important factors which may be taken into consideration, when assessing the overall level of concern are:

United Kingdom

Original text. Later amendments are not shown.

  1. (a)

    tumour type and background incidence;

  2. (b)

    multi-site responses;

  3. (c)

    progression of lesions to malignancy;

  4. (d)

    reduced tumour latency;

  5. (e)

    whether responses are in single or both sexes;

  6. (f)

    whether responses are in a single species or several species;

  7. (g)

    structural similarity to a substance(s) for which there is good evidence of carcinogenicity;

  8. (h)

    routes of exposure;

  9. (i)

    comparison of absorption, distribution, metabolism and excretion between test animals and humans;

  10. (j)

    the possibility of a confounding effect of excessive toxicity at test doses;

  11. (k)

    mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.

    Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.